<?xml version="1.0" encoding="UTF-8"?>
<p>Differences in inflammation and viral clearance after influenza challenge at long term may indicate changes in cellular responses; therefore, we assessed recall of influenza‐specific T cells (Figure 
 <xref rid="cti21107-fig-0006" ref-type="fig">6</xref>d) and B cells (Figure 
 <xref rid="cti21107-fig-0006" ref-type="fig">6</xref>e and f). Following influenza virus challenge, A‐eIIV mice showed increased H3N2‐1968‐specific polyfunctional CD8
 <sup>+</sup> T cells (IFN‐γ
 <sup>+</sup> TNF‐α
 <sup>+</sup> IL‐2
 <sup>+</sup>) in the bronchoalveolar lavage (BAL), whilst no other vaccination group had any substantial T‐cell response (Figure 
 <xref rid="cti21107-fig-0006" ref-type="fig">6</xref>d, A‐eIIV versus S‐IIV, 
 <italic>P</italic> = 0.005), whereas H3N2‐1968‐specific CD4
 <sup>+</sup> T‐cell responses were comparable between the vaccination groups in the lung draining mediastinal lymph node (mLN) (Supplementary figure 
 <xref rid="cti21107-sup-0001" ref-type="supplementary-material">4</xref>d and e). Furthermore, in the mLN, only A‐eIIV elicited a substantial recall of the H3N2‐2016 HA‐specific B‐cell response (Figure 
 <xref rid="cti21107-fig-0006" ref-type="fig">6</xref>e and f), which was twice the magnitude of S‐IIV (Figure 
 <xref rid="cti21107-fig-0006" ref-type="fig">6</xref>f, 
 <italic>P</italic> &lt; 0.0001). The A‐eIIV B‐cell recall responses at 6 months post‐vaccination also maintained elevated expression of B‐cell CSR‐ and SHM‐promoting responses for AID, Bcl6 and c‐Myc versus S‐IIV (Figure 
 <xref rid="cti21107-fig-0006" ref-type="fig">6</xref>g).
</p>
